Donald McCaffrey is the founder of Resverlogix. He has guided the company through the completion of Phase 2 clinical trials for RVX-208 and the enrollment.
Donald McCaffrey is the co-founder, President, and CEO of Resverlogix Corp., a biopharmaceutical company focused on treating chronic illnesses. He has guided the company through the completion of Phase 2 clinical trials for RVX-208 and the enrollment of its Phase 3 BETonMACE trial.
Full founder directory · Investor directory · Company funding database · Fundraising library